This contradicting data is consistent with the concept that, whilst being an important determinant of antiviral activity, the assessment of IL28B polymorphisms displays reduced predictive power in certain important subgroups of HCV patients, such as those in our study with treatment-related thyroiditis. The gene discussed is IFNL3; the disease is thyroiditis.